Dr Parvez Memet Shaikh, MD | |
1 Medical Center Drive, Morgantown, WV 26506 | |
(304) 598-4800 | |
Not Available |
Full Name | Dr Parvez Memet Shaikh |
---|---|
Gender | Male |
Speciality | Radiation Oncology |
Experience | 17 Years |
Location | 1 Medical Center Drive, Morgantown, West Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780840140 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
United Hospital Center | Bridgeport, WV | Hospital |
West Virginia University Hospitals | Morgantown, WV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
West Virginia University Medical Corporation | 1052224565 | 1613 |
United Hospital Center Inc | 8123936010 | 209 |
News Archive
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).
The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology.
› Verified 1 days ago
Entity Name | West Virginia University Medical Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).
The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology.
› Verified 1 days ago
Entity Name | United Hospital Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760965586 PECOS PAC ID: 8123936010 Enrollment ID: O20031212000802 |
News Archive
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).
The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Parvez Memet Shaikh, MD 1 Medical Center Drive, Morgantown, WV 26506 Ph: (304) 598-4800 | Dr Parvez Memet Shaikh, MD 1 Medical Center Drive, Morgantown, WV 26506 Ph: (304) 598-4800 |
News Archive
Patients with stable asthma who stop using low-dose inhaled corticosteroids are at a significantly increased risk for exacerbations over the following 6 months, show results from a systematic review and meta-analysis of published studies.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated a pilot Phase II study with ALN-TTRsc, a subcutaneously delivered RNAi therapeutic targeting the transthyretin gene in development for the treatment of TTR-mediated amyloidosis.
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to severe neurotrophic keratitis (NK).
The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology.
› Verified 1 days ago
Robert Grammer, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Brian Markovich, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-293-3091 | |
Mithra Kimyai-asadi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 Stadium Dr, Morgantown, WV 26506 Phone: 304-293-2463 | |
Dr. Gary D Marano, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 101 Stadium Dr, Morgantown, WV 26506 Phone: 304-598-4000 Fax: 304-293-6963 | |
Larissa Casaburi, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 6040 University Town Centre Dr, Morgantown, WV 26501 Phone: 304-293-6307 | |
Dr. Robert J Tallaksen, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 101 Stadium Dr, Morgantown, WV 26506 Phone: 304-598-4000 Fax: 304-293-6963 | |
Zalak Patel, Radiology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-293-2463 Fax: 304-293-5160 |